CVSA
Next earnings: Aug 6, 2026
Signal
Bearish Setup1!1
Price
1
Move-2.83%Negative session
Volume
1
Volume0.6× avgNormal activity
Technical
1
TrendRally vs TrendAbove 50D, below 200D
PRICE
Prev Close
126.51
Open
125.63
Day Range122.92 – 126.72
122.92
126.72
52W Range86.97 – 156.26
86.97
156.26
52% of range
VOLUME & SIZE
Avg Volume
354.3K
Float
34.0M
FUNDAMENTALS
P/E Ratio
17.9x
EPS (TTM)
$6.87
Div Yield
No dividend
Performance
1D
-2.83%
5D
+0.77%
1M
+9.28%
3M
+28.70%
6M
+27.43%
YTD
+18.81%
1Y
-5.73%
Best: 3M (+28.70%)Worst: 1Y (-5.73%)
Quick Read
Trend
UPTREND
Price above SMA50 & SMA200
Momentum
BULLISH
price above key MAs · revenue +10% YoY
Valuation
FAIR
P/E 18x vs ~20x sector
Health
MODERATE
CR 0.7 (low) · FCF $9.81/sh
Strong Buy
Key MetricsTTM
Market Cap$4.18B
Revenue TTM$1.91B
Net Income TTM$250.40M
Free Cash Flow$336.28M
Gross Margin58.0%
Net Margin13.1%
Operating Margin19.1%
Return on Equity17.8%
Return on Assets9.1%
Debt / Equity0.54
Current Ratio0.70
EPS TTM$7.30

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong1 watch2 concern
52/100
Liquidity
0.70Concern
Leverage
0.54Strong
Coverage
7.9xStrong
ROE
17.8%Strong
ROIC
12.8%Watch
Cash
$200MConcern
ANALYST COVERAGE2 analysts
BUY
+13.9%upside to target
Buy
2100%
2 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Stock Health
Composite Score
5 of 7 signals bullish
8/10
Trend
Trend StateUptrend (price above both MAs)
Above SMA 50$114.12 (+7.7%)
Above SMA 200$116.63 (+5.4%)
Technicals
MA AlignmentDeath Cross (50D vs 200D -2.1%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.70 — liquidity risk
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 28, 2026
In 104 days
Technicals
Market Position
Price Levels
52W High
$156.3+27.1%
Current
$122.9
SMA 200
$116.6-5.1%
SMA 50
$114.1-7.2%
52W Low
$86.97-29.3%
52-Week RangeMid-range
$86.9752th %ile$156.3
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$1.6B
$1.6B$1.6B
$4.93
±1%
Low2
FY2025
$1.8B
$1.8B$1.8B
+12.6%$6.54+32.6%
±1%
Low1
FY2026(current)
$1.9B
$1.9B$1.9B
+9.1%$8.02+22.6%
±1%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCVSA
Last 8Q
+9.5%avg beat
Beat 5 of 8 quartersMissed 2 Estimates rising
Q2'24
+4%
Q3'24
+45%
Q4'24
-4%
Q1'25
-6%
Q2'25
+11%
Q4'25
+11%
Q1'26
+14%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
2 Buys/4 SellsNet Selling
NET SELLERS$0 bought · $4.8M sold · 30d window
Phelan Robert J.CFO
$1.3M
May 8
SELL
Beck Douglas G.SVP, GC, Corp.…
$1.2M
May 8
SELL
Cox Karen SuePresident, Cha…
$249K
May 8
SELL
Beard, Stephen W.Chairman & CEO
$2.1M
May 8
SELL
Malafronte Michael WDir
$1.2M
Mar 10
BUY
Malafronte Michael WDir
$897K
Mar 11
BUY
Financials
News & Activity

CVSA News

About

No company information available

PeersConsumer Cyclical(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
CVSA
-2.83%
$264.14-1.15%$2.8T31.3+1237.8%1083.4%1521
$422.24-4.75%$1.6T352.3-293.1%400.1%1507
$297.51-2.25%$296.3B20.9+324.0%859.6%1477
$276.39+0.52%$196.4B22.6+372.3%3185.0%1478
$147.43+0.05%$163.2B30.2+711.9%910.0%1494
$218.42-2.32%$122.3B18.3+312.2%771.2%1489
Sector avg-1.82%79.3+444.2%1201.5%1494